No data available for drug.
DRUG INTERACTION
No drug interaction found for phylloquinone and .
meclofenamate
may enhance the anticoagulant effect of Vitamin K Antagonists
aspirin
may enhance the anticoagulant effect of Vitamin K Antagonists
floctafenine
may enhance the anticoagulant effect of Vitamin K Antagonists
sulindac
may enhance the anticoagulant effect of Vitamin K Antagonists
sparfloxacin
may enhance the anticoagulant effect of Vitamin K antagonists
primidone
may increase the metabolism of vitamin K antagonists
phenobarbital
may increase the metabolism of vitamin K antagonists
amobarbital
may increase the metabolism of vitamin K antagonists
butalbital
may increase the metabolism of vitamin K antagonists
butabarbital
may increase the metabolism of vitamin K antagonists
gemfibrozil
may enhance the anticoagulant effect of fibric acid derivatives
mefenamic acid
may increase the anti-coagulant effect of nonsteroidal anti-inflammatory agents
methohexital
may increase the CNS depressant effect of CNS depressants
cholestyramine
they may diminish the serum concentration when combined with vitamin k antagonists
miconazole
may enhance the serum concentration when combined with Vitamin K Antagonists
miconazole topical
It may enhance the serum concentration when combined with miconazole (topical)
allopurinol
allopurinol increases the effect of anticoagulation of vitamin K antagonists
citalopram
Selective Serotonin Reuptake Inhibitors may enhance the anticoagulant effect of Vitamin K
escitalopram
Selective Serotonin Reuptake Inhibitors may enhance the anticoagulant effect of Vitamin K
flibanserin
Selective Serotonin Reuptake Inhibitors may enhance the anticoagulant effect of Vitamin K
fluoxetine
Selective Serotonin Reuptake Inhibitors may enhance the anticoagulant effect of Vitamin K
mianserin
Selective Serotonin Reuptake Inhibitors may enhance the anticoagulant effect of Vitamin K
teduglutide
may increase the anticoagulant effect when combined with vitamin k antagonists
simvastatin
may increase the anticoagulant effect of vitamin K antagonist
atorvastatin
may increase the anticoagulant effect of vitamin K antagonist
cerivastatin
may increase the anticoagulant effect of vitamin K antagonist
fluvastatin
may increase the anticoagulant effect of vitamin K antagonist
tirzepatide
may have an increased anticoagulant effect when combined with vitamin k antagonists
exenatide
may have an increased anticoagulant effect when combined with vitamin k antagonists
lixisenatide
may have an increased anticoagulant effect when combined with vitamin k antagonists
abiraterone
It may enhance the serum concentration when combined with CYP2C9 Inhibitors
efavirenz
It may enhance the serum concentration when combined with CYP2C9 Inhibitors
potassium iodide
thyroid products increase the effect of anticoagulation of vitamin K antagonists
liotrix
thyroid products increase the effect of anticoagulation of vitamin K antagonists
propylthiouracil
thyroid products increase the effect of anticoagulation of vitamin K antagonists
retapamulin
it may diminish the excretion rate when combined with antibiotics, resulting in an enhanced serum level
aspirin
Vitamin K antagonists: they may increase the antiplatelet effect of antiplatelet agents
defibrotide sodium
Vitamin K antagonists: they may increase the antiplatelet effect of antiplatelet agents
tirofiban
Vitamin K antagonists: they may increase the antiplatelet effect of antiplatelet agents
vorapaxar
Vitamin K antagonists: they may increase the antiplatelet effect of antiplatelet agents
acetylsalicylic acid
Vitamin K antagonists: they may increase the antiplatelet effect of antiplatelet agents
primidone
may increase the metabolism of Vitamin K Antagonists
phenobarbital
may increase the metabolism of Vitamin K Antagonists
amobarbital
may increase the metabolism of Vitamin K Antagonists
butalbital
may increase the metabolism of Vitamin K Antagonists
butabarbital
may increase the metabolism of Vitamin K Antagonists
ibalizumab
may diminish the anticoagulant effect of Vitamin K Antagonists
dolutegravir
may diminish the anticoagulant effect of Vitamin K Antagonists
tecovirimat
may diminish the anticoagulant effect of Vitamin K Antagonists
rosuvastatin
may enhance the anticoagulant effect of Vitamin K Antagonists
simvastatin
may enhance the anticoagulant effect of Vitamin K Antagonists
atorvastatin
may enhance the anticoagulant effect of Vitamin K Antagonists
cerivastatin
may enhance the anticoagulant effect of Vitamin K Antagonists
etonogestrel
may increase the serum concentration of Vitamin K Antagonists
fidaxomicin
may increase the serum concentration of Vitamin K Antagonists
azithromycin
may increase the serum concentration of Vitamin K Antagonists
trazodone
may enhance the anticoagulant effect of Vitamin K antagonists
vilazodone
may enhance the anticoagulant effect of Vitamin K antagonists
vortioxetine
may enhance the anticoagulant effect of Vitamin K antagonists
citalopram
may enhance the anticoagulant effect of Vitamin K antagonists
escitalopram
may enhance the anticoagulant effect of Vitamin K antagonists
metformin
may diminish the anticoagulant effect of Vitamin K Antagonists
cefiderocol
cephalosporins increase the effect of anticoagulation of vitamin K antagonists
cephalothin
cephalosporins increase the effect of anticoagulation of vitamin K antagonists
cefonicid
cephalosporins increase the effect of anticoagulation of vitamin K antagonists
ceftizoxime
cephalosporins increase the effect of anticoagulation of vitamin K antagonists
cefoperazone
cephalosporins increase the effect of anticoagulation of vitamin K antagonists
ceforanide
cephalosporins may enhance the anticoagulant effect of vitamin K antagonists
ceftriaxone
cephalosporins may enhance the anticoagulant effect of vitamin K antagonists
cefotaxime
cephalosporins may enhance the anticoagulant effect of vitamin K antagonists
metformin
metformin reduces the effect of anticoagulation of vitamin K antagonists
dalteparin
may increase the anti-coagulant action of anti-coagulants
cefuroxime
may enhance the anticoagulant effect of Vitamin K antagonists
cefotetan
may enhance the anticoagulant effect of Vitamin K antagonists
simeprevir
may decrease the anticoagulant effect of direct-acting viral agents
cefazolin
may increase the anticoagulant effect of cephalosporins
cefoxitin
may increase the anticoagulant effect of cephalosporins
hydroxychloroquine
may have an increased anticoagulant effect when combined with vitamin k antagonists
sparfloxacin
may have an increased anticoagulant effect when combined with vitamin k antagonists
ivermectin
may have an increased anticoagulant effect when combined with vitamin k antagonists
cefmetazole
may increase the anticoagulant effect of vitamin K antagonists
ethinyl estradiol
may increase the levels of serum concentration of vitamin K antagonists
ethinylestradiol
may increase the levels of serum concentration of vitamin K antagonists
etonogestrel
may increase the levels of serum concentration of vitamin K antagonists
cefalotin
may increase the anticoagulant effect
efavirenz
May decrease the serum concentration
maralixibat
may increase the levels of serum concentration
lenacapavir
may increase the levels of serum concentration
diacerein
may increase the levels of serum concentration
oxacillin
may increase the anticoagulant effect
acetaminophen
may have an increased anticoagulant effect when combined with vitamin k antagonists
lovastatin
may increase the anticoagulant effect of HMG-CoA Reductase Inhibitors
liotrix
may increase the anticoagulant effect
balsalazide
5-Aminosalicylic Acid Derivatives: they may increase the anticoagulant effect of Vitamin K Antagonists
sulfasalazine
5-Aminosalicylic Acid Derivatives: they may increase the anticoagulant effect of Vitamin K Antagonists
daclatasvir
may decrease the anticoagulant effect of Direct Acting Antiviral Agents
etonogestrel
may enhance the serum concentration of Hormonal Contraceptives
dicumarol
may have an increased anticoagulant effect when combined with vitamin k antagonists
anisindione
may have an increased anticoagulant effect when combined with vitamin k antagonists
heparin
may have an increased anticoagulant effect when combined with vitamin k antagonists
enoxaparin
may have an increased anticoagulant effect when combined with vitamin k antagonists
dalteparin
may have an increased anticoagulant effect when combined with vitamin k antagonists
tirzepatide
may have an increased anticoagulant effect when combined with vitamin k antagonists
exenatide
may have an increased anticoagulant effect when combined with vitamin k antagonists
lixisenatide
may have an increased anticoagulant effect when combined with vitamin k antagonists
oxaceprol
oxaceprol decreases the effect of vitamin K antagonists
oxandrolone
androgens increase the effect of anticoagulation of vitamin K antagonists like warfarin
nandrolone
androgens increase the effect of anticoagulation of vitamin K antagonists like warfarin
fluoxymesterone
androgens increase the effect of anticoagulation of vitamin K antagonists like warfarin
nandrolone decanoate
androgens increase the effect of anticoagulation of vitamin K antagonists like warfarin
clofibrate
fibric acid derivatives increase the effect of anticoagulation of vitamin K antagonists
fenofibrate
fibric acid derivatives increase the effect of anticoagulation of vitamin K antagonists
fenofibric acid
fibric acid derivatives increase the effect of anticoagulation of vitamin K antagonists
gemfibrozil
fibric acid derivatives increase the effect of anticoagulation of vitamin K antagonists
bezafibrate
fibric acid derivatives increase the effect of anticoagulation of vitamin K antagonists
nandrolone decanoate
androgens increase the effect of anticoagulation of vitamin K antagonists like warfarin
No data available for drug.
DRUG INTERACTION
phylloquinone
&
No Drug Intearction Found. for phylloquinone and .
meclofenamate
may enhance the anticoagulant effect of Vitamin K Antagonists
aspirin
may enhance the anticoagulant effect of Vitamin K Antagonists
floctafenine
may enhance the anticoagulant effect of Vitamin K Antagonists
sulindac
may enhance the anticoagulant effect of Vitamin K Antagonists
sparfloxacin
may enhance the anticoagulant effect of Vitamin K antagonists
primidone
may increase the metabolism of vitamin K antagonists
phenobarbital
may increase the metabolism of vitamin K antagonists
amobarbital
may increase the metabolism of vitamin K antagonists
butalbital
may increase the metabolism of vitamin K antagonists
butabarbital
may increase the metabolism of vitamin K antagonists
gemfibrozil
may enhance the anticoagulant effect of fibric acid derivatives
mefenamic acid
may increase the anti-coagulant effect of nonsteroidal anti-inflammatory agents
methohexital
may increase the CNS depressant effect of CNS depressants
cholestyramine
they may diminish the serum concentration when combined with vitamin k antagonists
miconazole
may enhance the serum concentration when combined with Vitamin K Antagonists
miconazole topical
It may enhance the serum concentration when combined with miconazole (topical)
allopurinol
allopurinol increases the effect of anticoagulation of vitamin K antagonists
citalopram
Selective Serotonin Reuptake Inhibitors may enhance the anticoagulant effect of Vitamin K
escitalopram
Selective Serotonin Reuptake Inhibitors may enhance the anticoagulant effect of Vitamin K
flibanserin
Selective Serotonin Reuptake Inhibitors may enhance the anticoagulant effect of Vitamin K
fluoxetine
Selective Serotonin Reuptake Inhibitors may enhance the anticoagulant effect of Vitamin K
mianserin
Selective Serotonin Reuptake Inhibitors may enhance the anticoagulant effect of Vitamin K
teduglutide
may increase the anticoagulant effect when combined with vitamin k antagonists
simvastatin
may increase the anticoagulant effect of vitamin K antagonist
atorvastatin
may increase the anticoagulant effect of vitamin K antagonist
cerivastatin
may increase the anticoagulant effect of vitamin K antagonist